Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. It focuses on five business areas: gastroenterology, rare diseases, plasma-derived therapies immunology, oncology, and neuroscience. The company offers treatments for complex perianal fistulas, acid-related diseases, cell lung cancer, and hormone-responsive cancers, as well as enzyme replacement therapy, inhibitors, and other products.